Back to Newsroom
Back to Newsroom

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Investors are Encouraged to Contact the Firm - CBMG, PTI, VRTU, IMMU

Monday, 12 October 2020 08:00 AM

Halper Sadeh LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / October 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:

Halper Sadeh LLP , Monday, October 12, 2020, Press release picture

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/cellular-biomedicine-group-inc-cbmg-stock-merger/.

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Yumanity Therapeutics. Under the terms of the merger agreement, Proteostasis will acquire all outstanding shares of Yumanity in exchange for newly-issued shares of Proteostasis common stock, with existing Proteostasis shareholders expected to own approximately 32.5% of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/proteostasis-therapeutics-inc-pti-yumanity-stock-merger/.

Virtusa Corporation (NASDAQ:VRTU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds affiliated with Baring Private Equity Asia for $51.35 per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/virtusa-corporation-vrtu-stock-merger-baring-asia/.

Immunomedics, Inc. (NASDAQ:IMMU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Gilead Sciences, Inc. for $88.00 per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/immunomedics-merger-stock-gilead.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP 

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: